B-ALL patients show an increased microvascularization in the BM associated to an increase in most of the cases of the pro-angiogenic factor basic fibroblast growth factor (bFGF) but not of vascular endothelial growth factor (VEGF) (77, 78). This evidence concerns the gene VEGFA and precursor B-cell acute lymphoblastic leukemia.